CANN GROUP LIMITED — Director's Dealing 2018

Dec 18, 2018

==> picture [585 x 60] intentionally omitted <==

ASX ANNOUNCEMENT

19 DECEMBER 2018

CHANGE OF DIRECTOR’S INTEREST

Please find following the Change of Director’s Interest Notice (Appendix 3Y) for purchases by Mr Philip Jacobsen.

Richard Baker

Company Secretary

Cann Group Limited

For further information please contact:

Peter Crock Matthew Wright Cann Group Limited NWR Communications +61 (0) 3 9095 7088 +61 (0) 451 896 420 contact@canngrouplimited.com matt@nwrcommunications.com.au

About Cann Group

Cann Group is building a world-class business focused on breeding, cultivating and manufacturing medicinal cannabis for sale and use within Australia. The company has established research and cultivation facilities in Melbourne and is striving to provide access to medicinal cannabis for Australian patients. Cann Group has executed collaboration agreements that will enable it to establish a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions. It was issued with Australia’s first medicinal cannabis research licence in February 2017, in addition to Australia’s first medicinal cannabis cultivation licence in March 2017. Aurora Cannabis Inc – one of Canada’s largest listed medicinal cannabis company – is a cornerstone investor in Cann, with a 22.9% shareholding.

==> picture [595 x 78] intentionally omitted <==

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity CANN GROUP LIMITED

ABN 25 603 949 739

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	PHILIP JACOBSEN
Date of last notice	25 JANUARY 2018

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

	Direct or indirect interest	Direct or indirect interest	DIRECT	DIRECT	DIRECT
	Nature of indirect interest		PHILIP JACOBSEN AND MAXINE JACOBSEN•Trustee of Jayess Super Fund; and•Member of Jayess Super Fund
	(including registered holder)
	Note: Provide details of the circuinterest.	mstances giving rise to the relevant	•T	rustee of Jayess Super Fund; andf
			•	ember o Jayess Super Fund
	Date of change		14 DECEM	BER 2018
			17 DECEM	BER 2018 AND
	No. of securities held prior to change		4,064,518
	Class		FULLY PAID ORDINARY SHARES
	Number acquired		20,000
	Number disposed		NIL
	Value/Consideration		$41,242.5	1
	Note: If consideration is non-cvaluation	ash, provide details and estimated
	No. of securities held after change

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buyback

ON-MARKET PURCHASE

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract inrelation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	N/A
If so, was prior written clearance provided to allow thetrade to proceed during this period?	N/A
If prior written clearance was provided, on what date wasthis provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011